HIGHLIGHTS
- What: The main analysis of this study showed that, in RCT-based studies, there was no significant difference in all-cause mortality, cardiovascular mortality, or noncardiovascular mortality between Fourth, most of the patients with multivessel lesions who were included in the study had STEMI, and there is currently no guidance for the staged revascularization strategy for multivessel lesions in non-STEMI patients.
- Who: Yi Chen from the (UNIVERSITY) have published the research: The optimal timing for intervention in patients with ST-segment elevation myocardial infarction and multivessel disease: a systematic review andmeta-analysis, in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.